Sanofi Completes $9.5B Buy Of Blueprint
French multinational pharmaceutical company Sanofi, led by Weil Gotshal & Manges LLP, said Friday that it has completed the up to $9.5 billion acquisition of its U.S. rival Blueprint Medicines Corp.,...To view the full article, register now.
Already a subscriber? Click here to view full article